After years of scientific exploration and concept development, work began on transforming the original idea into a structured biotechnology company. The long-term vision expanded beyond a single product toward building a scalable pharmaceutical platform dedicated to advancing THCA-based therapeutics through scientific research, clinical development, and strategic partnerships.